 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Chaperone
|
 |
|
Title:
|
 |
Solution structure of the bag domain from bag4/sodd
|
|
Structure:
|
 |
Bag-family molecular chaperone regulator-4. Chain: a. Fragment: bag domain (residues 371-457). Synonym: silencer of death domains. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: bag4/sodd. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
NMR struc:
|
 |
25 models
|
 |
|
Authors:
|
 |
K.Briknarova,S.Takayama,S.Homma,K.Baker,E.Cabezas,D.W.Hoyt, Z.Li,A.C.Satterthwait,K.R.Ely
|
Key ref:
|
 |
K.Briknarová
et al.
(2002).
BAG4/SODD protein contains a short BAG domain.
J Biol Chem,
277,
31172-31178.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-Jul-02
|
Release date:
|
24-Jul-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
O95429
(BAG4_HUMAN) -
BAG family molecular chaperone regulator 4
|
|
|
|
Seq: Struc:
|
 |
 |
 |
457 a.a.
87 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
chaperone binding
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
277:31172-31178
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
BAG4/SODD protein contains a short BAG domain.
|
|
K.Briknarová,
S.Takayama,
S.Homma,
K.Baker,
E.Cabezas,
D.W.Hoyt,
Z.Li,
A.C.Satterthwait,
K.R.Ely.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BAG (Bcl-2-associated athanogene) proteins are molecular chaperone regulators
that affect diverse cellular pathways. All members share a conserved motif,
called the BAG domain (BD), which binds to Hsp70/Hsc70 family proteins and
modulates their activity. We have determined the solution structure of BD from
BAG4/SODD (silencer of death domains) by multidimensional nuclear magnetic
resonance methods and compared it to the corresponding domain in BAG1
(Briknarová, K., Takayama, S., Brive, L., Havert, M. L., Knee, D. A., Velasco,
J., Homma, S., Cabezas, E., Stuart, J., Hoyt, D. W., Satterthwait, A. C.,
Llinás, M., Reed, J. C., and Ely, K. R. (2001) Nat. Struct. Biol. 8, 349-352).
The difference between BDs from these two BAG proteins is striking, and the
structural comparison defines two subfamilies of mammalian BD-containing
proteins. One subfamily includes the closely related BAG3, BAG4, and BAG5
proteins, and the other is represented by BAG1, which contains a structurally
and evolutionarily distinct BD. BDs from both BAG1 and BAG4 are three-helix
bundles; however, in BAG4, each helix in this bundle is three to four turns
shorter than its counterpart in BAG1, which reduces the length of the domain by
one-third. BAG4 BD thus represents a prototype of the minimal functional
fragment that is capable of binding to Hsc70 and modulating its chaperone
activity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Fig. 4. Surface maps of BAG4 BD. In panels a and b, the
solvent accessible surface of the domain is colored according to
electrostatic potential. Areas with negative, positive, or
neutral character are depicted in red, blue, or white,
respectively. In panel a, the view is the same as in Fig. 2,
with helices 2 and 3 and the Hsc70 binding site facing forward.
In panel b, the molecule is rotated 180° around a vertical
axis relative to the view in panel a, thus revealing the
opposite side with helix 1 in front. In panels c and d, the
surface is colored according to hydrophobicity. Yellow color
intensity is proportional to increasing hydrophobic character,
and the front and back views of the molecule are displayed as in
panels a and b. Charged and hydrophobic residues are labeled in
the appropriate panels.
|
 |
Figure 5.
Fig. 5. A comparative gallery of BAG domains. Contact
surfaces of BDs from BAG1, BAG3, BAG4, and BAG5 (columns 1-9),
whose sequences are aligned in Fig. 2, are colored according to
electrostatic potential (rows 1 and 2) and hydrophobicity (rows
3 and 4). Residues 99-210 of murine BAG1 (PDB ID 1I6Z), residues
99-205 of human BAG3 (PDB ID 1HX1), residues 376-457 of human
BAG4, and corresponding residues from homology models of BAG3
and BAG5 BDs are shown. Coloring and orientation are the same as
in Fig. 4 to permit direct comparison. Front views are shown in
rows 1 and 3, whereas back views are presented in rows 2 and 4.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2002,
277,
31172-31178)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.V.Kalia,
S.K.Kalia,
H.Chau,
A.M.Lozano,
B.T.Hyman,
and
P.J.McLean
(2011).
Ubiquitinylation of α-Synuclein by Carboxyl Terminus Hsp70-Interacting Protein (CHIP) Is Regulated by Bcl-2-Associated Athanogene 5 (BAG5).
|
| |
PLoS One, 6,
e14695.
|
 |
|
|
|
|
 |
A.Arakawa,
N.Handa,
N.Ohsawa,
M.Shida,
T.Kigawa,
F.Hayashi,
M.Shirouzu,
and
S.Yokoyama
(2010).
The C-terminal BAG domain of BAG5 induces conformational changes of the Hsp70 nucleotide-binding domain for ADP-ATP exchange.
|
| |
Structure, 18,
309-319.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Rosati,
K.Khalili,
S.L.Deshmane,
S.Radhakrishnan,
M.Pascale,
M.C.Turco,
and
L.Marzullo
(2009).
BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells.
|
| |
J Cell Physiol, 218,
264-267.
|
 |
|
|
|
|
 |
L.Sun,
L.Huang,
P.Nguyen,
K.S.Bisht,
G.Bar-Sela,
A.S.Ho,
C.M.Bradbury,
W.Yu,
H.Cui,
S.Lee,
J.B.Trepel,
A.P.Feinberg,
and
D.Gius
(2008).
DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation.
|
| |
Cancer Res, 68,
2726-2735.
|
 |
|
|
|
|
 |
A.Rosati,
A.Leone,
L.Del Valle,
S.Amini,
K.Khalili,
and
M.C.Turco
(2007).
Evidence for BAG3 modulation of HIV-1 gene transcription.
|
| |
J Cell Physiol, 210,
676-683.
|
 |
|
|
|
|
 |
A.Rosati,
M.Ammirante,
A.Gentilella,
A.Basile,
M.Festa,
M.Pascale,
L.Marzullo,
M.A.Belisario,
A.Tosco,
S.Franceschelli,
O.Moltedo,
G.Pagliuca,
R.Lerose,
and
M.C.Turco
(2007).
Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein.
|
| |
Int J Biochem Cell Biol, 39,
1337-1342.
|
 |
|
|
|
|
 |
M.Coulson,
S.Robert,
and
R.Saint
(2005).
Drosophila starvin encodes a tissue-specific BAG-domain protein required for larval food uptake.
|
| |
Genetics, 171,
1799-1812.
|
 |
|
|
|
|
 |
M.P.Mayer,
and
B.Bukau
(2005).
Hsp70 chaperones: cellular functions and molecular mechanism.
|
| |
Cell Mol Life Sci, 62,
670-684.
|
 |
|
|
|
|
 |
S.K.Kalia,
S.Lee,
P.D.Smith,
L.Liu,
S.J.Crocker,
T.E.Thorarinsdottir,
J.R.Glover,
E.A.Fon,
D.S.Park,
and
A.M.Lozano
(2004).
BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.
|
| |
Neuron, 44,
931-945.
|
 |
|
|
|
|
 |
P.A.Townsend,
R.I.Cutress,
A.Sharp,
M.Brimmell,
and
G.Packham
(2003).
BAG-1: a multifunctional regulator of cell growth and survival.
|
| |
Biochim Biophys Acta, 1603,
83-98.
|
 |
|
|
|
|
 |
R.Endres,
G.Häcker,
I.Brosch,
and
K.Pfeffer
(2003).
Apparently normal tumor necrosis factor receptor 1 signaling in the absence of the silencer of death domains.
|
| |
Mol Cell Biol, 23,
6609-6617.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|